Wilkinson Eric P, Roberts Daniel S, Cassis Adam, Schwartz Marc S
House Clinic, Los Angeles, California, United States.
Department of Otolaryngology, West Virginia University Hospital, Morgantown, West Virginia, United States.
J Neurol Surg B Skull Base. 2016 Aug;77(4):333-40. doi: 10.1055/s-0035-1571166. Epub 2016 Feb 13.
The objective of this study was to evaluate hearing outcomes following middle fossa (MF) or retrosigmoid (RS) craniotomy for vestibular schwannoma (VS) removal with the goal of hearing preservation.
This is a retrospective series.
This study was set at a skull base referral center.
In this study, 377 sporadic VS patients underwent primary microsurgery for VS from 2002 to 2012 using the MF (n = 305) or RS (n = 72) approaches.
The main outcome measures were change in pure-tone average (PTA) and word recognition score from pre- to postoperative and surgical complications.
Preoperative hearing did not differ between approaches. Tumors were larger in the RS group (mean = 1.78 cm) than the MF group (mean = 0.97 cm) (p ≤ 0.001). Mean times to last audiometric follow-up were MF 1.0 year and RS 0.7 years. Mean decline in hearing from preoperative to last follow-up was greater in the RS group (55.5 dB in PTA and 45.6% in discrimination) than the MF group (38.9 dB and 31.7%) (p ≤ 0.011 and 0.033, respectively). The effect of surgical approach on hearing outcome remained after controlling for tumor size. Facial nerve outcomes and cerebrospinal fluid leak rates were not significantly different.
Loss of hearing was greater with the RS approach than the MF approach, even when accounting for differences in tumor size. Postoperative facial nerve function and other complications did not differ between approaches.
本研究的目的是评估采用中颅窝(MF)或乙状窦后(RS)开颅术切除前庭神经鞘瘤(VS)以保留听力后的听力结果。
这是一项回顾性系列研究。
本研究在一个颅底转诊中心进行。
在本研究中,377例散发VS患者在2002年至2012年间接受了VS的初次显微手术,采用MF(n = 305)或RS(n = 72)入路。
主要观察指标为术前至术后纯音平均听阈(PTA)和言语识别率的变化以及手术并发症。
两种入路术前听力无差异。RS组肿瘤(平均 = 1.78 cm)比MF组(平均 = 0.97 cm)更大(p≤0.001)。最后一次听力随访的平均时间MF组为1.0年,RS组为0.7年。从术前到最后一次随访,RS组听力平均下降幅度大于MF组(PTA下降55.5 dB,辨别率下降45.6%)(MF组分别为38.9 dB和31.7%)(p分别≤0.011和0.033)。在控制肿瘤大小后,手术入路对听力结果的影响仍然存在。面神经结果和脑脊液漏发生率无显著差异。
即使考虑肿瘤大小差异,RS入路导致的听力损失也比MF入路更大。两种入路术后面神经功能和其他并发症无差异。